Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiation Injuries × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Melanoma 2 Lymphoma, T-Cell 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of Lung 1

Interventions

Radiotherapy 25 Amifostine 10 Cisplatin 9 Paclitaxel 7 Carboplatin 6 Etoposide 5 Radiotherapy, Intensity-Modulated 4 Radiosurgery 4 Donepezil 4 Surgical Procedures, Operative 3 Mental Status and Dementia Tests 3 Filgrastim 3 Diet Therapy 3 Brachytherapy 3 Blood Specimen Collection 3 Bevacizumab 3 sargramostim 2 Radiation 2 Proton Therapy 2 Magnetic Resonance Spectroscopy 2 Low-Level Light Therapy 2 Lithium 2 Hyperbaric Oxygenation 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Adrenal Cortex Hormones 2 sodium propionate 1 olaparib 1 lithium sulfate 1 ethanethiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04274270 2020-03-19

SBRTLCES

Peking University Third Hospital

Phase NA Unknown

Lung Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡